HRA001884
Title:
Longitudinal circulating tumor DNA (ctDNA) profiling in metastatic colorectal cancer patients during anti-EGFR therapy
Release date:
2022-01-27
Description:
Metastatic colorectal cancer (mCRC) is a heterogenous disease with limited precision medicine and targeted therapy options. Monoclonal antibodies against epidermal growth factor receptor (EGFR) have been a crucial treatment option for mCRC. However, proper biomarkers for predicting therapeutic response remain unknown. As a non-invasive test, circulating tumor DNA (ctDNA) is appropriately positioned to reveal tumor heterogeneity and evolution, as it can be used in real-time genomic profiling. To evaluate the significance of ctDNA in monitoring the dynamic therapeutic response and prognosis of mCRC, we detected the baseline and dynamic changes of ctDNA in mCRC patients receiving anti-EGFR therapies.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
colorectal adenocarcinoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
CRC
Contact person:
Chen Zhiyu
Email:
chanhj75@aliyun.com
Description:
This DAC was built for data request from others.
Individuals & samples
Submitter:   Liu Dongyu / dongyu.liu@3dmedcare.com
Organization:   3D Medicines Inc.
Submission date:   2022-01-26
Requests:   -